3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
111
Lung Neoplasms
54
Adenocarcinoma of Lung
10
Breast Neoplasms
9
Small Cell Lung Carcinoma
5
Neoplasms
5
Mesothelioma, Malignant
5
NSCLC
4
Mesothelioma
3
Adenocarcinoma, Bronchiolo-Alveolar
3
Thoracic Neoplasms
2
Recurrence
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Non-small Cell Lung Cancer Metastatic
2
Lung Diseases
2
Carcinoma, Ovarian Epithelial
2
Advanced Non-Small Cell Lung Cancer
2
Adenocarcinoma
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Sarcoma
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Pleural Effusion, Malignant
1
Pheochromocytoma
1
Paraganglioma, Extra-Adrenal
1
Pancreatic Neoplasms
1
Non-small Cell Lung Cancer Stage â…¡
1
Interventions
tremelimumab
1
durvalumab
1
Vinorelbine
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non - Small Cell Lung Cancer NSCLC
×
Vinorelbine
×
Thoracic
×
Clear all
NCT02352948
2024-07-26
ARCTIC
AstraZeneca
Phase 3
Completed
597 enrolled
23 charts